N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|35|5135-5143

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.35, 2015-10, pp. : 5135-5143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Thymosin-β4 and its Derivative N -acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in Cardiac Healing After Infarction

By Cavasin Maria A.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Mitochondrial Aldehyde Dehydrogenase, A Potential Drug Target for Protection of Heart and Brain from Ischemia/Reperfusion Injury

By  

Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. : 948-955

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM9 as a Potential Target Molecule in Cancer

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2282-2287

Bentham Science Publishers

Access to resources Recommend Favorite

The Brain Endothelin System as Potential Target for Brain-Related Pathologies

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 6, 2002-12 ,pp. : 543-553

Bentham Science Publishers

Access to resources Recommend Favorite

Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers

By  

Current Cancer Drug Targets, Vol. 4, Iss. 7, 2004-11 ,pp. : 591-596

Bentham Science Publishers

Access to resources Recommend Favorite